We report a case of a de novo ring 21 complex chromosomal rearrangement in a fetus presenting with hydrops. Noninvasive prenatal testing (NIPT) failed to detect the imbalance. This case highlights the need to understand the various limitations and strengths of NIPT technology when counseling patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878046 | PMC |
| http://dx.doi.org/10.1002/ccr3.2369 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The efficacy of expanded non-invasive prenatal testing (NIPT) in a high-risk twin pregnancies cohort.
Acta Obstet Gynecol Scand
December 2024
Department of Fetal Medicine & Prenatal Diagnosis Center, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.
Introduction: Our objective was to evaluate the efficacy of expanded non-invasive prenatal testing (NIPT) that includes both trisomies and copy number variants (CNVs) in high-risk twin pregnancies.
Material And Methods: A prospective, double-blinded cohort study was conducted, enrolling 73 high-risk twin pregnancies characterized by increased risk of genetic disorders due to factors such as increased nuchal translucency, structural anomalies, fetal growth restriction, and other factors associated with chromosomal abnormality. Participants underwent invasive karyotyping and chromosomal microarray analysis, alongside separate expanded NIPT for research purposes.
Article Synopsis
- Preterm birth is a major cause of perinatal death, and this study evaluates the effectiveness of antenatal care for women giving birth prematurely.
- The research involved a review of 161 women who delivered preterm and assessed their care quality, finding that only about 43% of high-risk and 50% of low-risk cases received 'good' care.
- Key issues identified included a lack of cervical length assessments and inadequate screening for bacterial vaginosis in high-risk patients, highlighting areas for potential improvement in care practices.
Uterine fibroids and non-informative cell-free DNA screening results.
Ultrasound Obstet Gynecol
October 2024
Monash Ultrasound for Women, Melbourne, Australia.
Objective: Uterine fibroids are monoclonal tumors, which are often genetically abnormal and associated with false-positive genome-wide cell-free DNA (cfDNA) screening results, particularly when large. It is plausible that fibroids may also increase the risk of cfDNA failure by affecting fetal fraction or due to their genetic anomalies confounding cfDNA algorithms. We aimed to investigate a possible association between fibroids and cfDNA non-informative results.
View Article and Find Full Text PDFEarly Non-Invasive Prenatal Testing at 6-9 Weeks of Gestation.
Genes (Basel)
July 2024
Obstetrics and Gynecology, University Hospital of Ioannina, 455 00 Ioannina, Greece.
Non-invasive prenatal testing (NIPT) is usually performed beyond 10 weeks of gestation, because earlier in pregnancy, the fetal fraction is low, resulting in failure to obtain reliable results. This study aimed to evaluate the clinical performance of NIPT earlier in pregnancy using a method for cell-free DNA (cfDNA) analysis that eliminates the need for polymerase chain reaction (PCR), DNA sequencing, or microarrays (Vanadis system, PerkinElmer, Waltham, MA, USA). Cell-free DNA was extracted from the maternal plasma of 30 singleton pregnancies at 6-9 weeks of gestation (group 1) and at 11-14 weeks of gestation of the same patients (group 2).
View Article and Find Full Text PDFAccuracy of expanded noninvasive prenatal testing for maternal copy number variations: A comparative study with CNV-seq of maternal lymphocyte DNA.
Taiwan J Obstet Gynecol
July 2024
Center for Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Electronic address:
Objective: To evaluate the accuracy of expanded noninvasive prenatal testing (NIPT) for maternal copy number variations.
Materials And Methods: Expanded NIPT was used to detect CNVs ≥2 Mb at a whole-genome scale. The threshold of maternal deletion was copy numbers (CN) ≤ 1.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!